The H100 Analyzer: Merging Diabetes and Genetic Screening in One Lab Workflow

H100 Hemoglobin Analyzer (HbA1c HPLC System) – High-Precision Diabetes & Thalassemia Testing

The H100 is a fully automated HPLC system built for HbA1c measurement and hemoglobin variant detection. It targets two distinct clinical needs — diabetes management and β-thalassemia screening — within a single instrument cycle.

Its key operational spec is speed: 96 seconds per HbA1c test, with NGSP and IFCC certification. The thalassemia mode is slower, at 350 seconds, but automatic mode switching removes the need for separate sample runs or reagent changes.

The system holds 50 to 110 sample positions, with a stat slot for urgent cases. The 10.1-inch touchscreen and Linux interface reduce training overhead, while onboard storage of 20,000 results supports traceability protocols.

From a procurement standpoint, the H100 reduces capital equipment count. A medium-sized lab can cover chronic disease monitoring and genetic screening on one bench, compressing both floor space and maintenance costs.

Chinese manufacturers are increasingly exporting such dual-mode analyzers to Southeast Asia and Africa, where thalassemia prevalence is high and diabetes screening infrastructure is still being built. The H100 fits that demand precisely.

This is not a breakthrough technology — it is efficient packaging of proven HPLC into a configuration that solves real resource constraints. That is where the industrial value lies.

Why it matters:
For labs operating on tight margins and mixed caseloads, the H100 removes a core operational friction: instrument proliferation. It also hints at a broader move by Chinese OEMs to dominate mid-tier diagnostic automation by bundling assays rather than just competing on price.

View Product →